Drug comparisons
Semaglutide vs Repaglinide
Semaglutide vs Repaglinide for T2D: GLP-1 agonist vs meglitinide. Compare A1c, weight loss, CV benefits vs postprandial control and hypo risk.
No comparison dimensions are available for this page.
Clinical context
This comparison is relevant when choosing oral agents for type 2 diabetes, especially oral GLP-1 (Rybelsus) versus a mealtime meglitinide in patients needing postprandial coverage.
Bottom line
Semaglutide is generally preferred for broader metabolic and CV benefits, while Repaglinide suits flexible mealtime dosing with functioning beta cells.
All medication comparisons